Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Closed loop developments to improve glucose control at home.

Renard E, Cobelli C, Kovatchev BP.

Diabetes Res Clin Pract. 2013 Nov;102(2):79-85. doi: 10.1016/j.diabres.2013.09.009. Review.

PMID:
24128998
2.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.

3.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.

4.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
5.

Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.

Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R.

CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265.

6.

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.

7.

Who needs an artificial pancreas? (?).

Winikoff J, Drexler A.

J Diabetes. 2013 Sep;5(3):254-7. doi: 10.1111/1753-0407.12052. Review.

PMID:
23601378
8.

Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.

Tauschmann M, Hovorka R.

Expert Opin Drug Deliv. 2014 Jun;11(6):943-55. doi: 10.1517/17425247.2014.910192. Review.

PMID:
24749563
9.

AP@home: a novel European approach to bring the artificial pancreas home.

Heinemann L, Benesch C, DeVries JH.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1363-72.

10.

Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.

Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1374-81.

11.

The artificial pancreas: current status and future prospects in the management of diabetes.

Peyser T, Dassau E, Breton M, Skyler JS.

Ann N Y Acad Sci. 2014 Apr;1311:102-23. doi: 10.1111/nyas.12431. Review.

PMID:
24725149
12.

The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.

Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T, Avbelj M, Miller S, Muller I, Phillip M, Battelino T.

Pediatr Diabetes. 2013 May;14(3):159-67. doi: 10.1111/pedi.12025.

PMID:
23448393
13.

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.

Diabetes Care. 2008 May;31(5):934-9. doi: 10.2337/dc07-1967.

PMID:
18252903
14.

Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.

Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd.

J Diabetes Sci Technol. 2010 Jul 1;4(4):961-75.

15.

Closed loop insulin delivery in diabetes.

Battelino T, Omladič JŠ, Phillip M.

Best Pract Res Clin Endocrinol Metab. 2015 Jun;29(3):315-25. doi: 10.1016/j.beem.2015.03.001. Review.

PMID:
26051293
16.

Towards an artificial pancreas at home.

Renard E, Farret A, Place J, Wojtusciszyn A, Bringer J.

Diabetes Metab. 2011 Dec;37 Suppl 4:S94-8. doi: 10.1016/S1262-3636(11)70973-9.

17.

Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.

Magni L, Forgione M, Toffanin C, Dalla Man C, Kovatchev B, De Nicolao G, Cobelli C.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1091-8.

18.

Postprandial glycemic excursions with the use of a closed-loop platform in subjects with type 1 diabetes: a pilot study.

van Bon AC, Hermanides J, Koops R, Hoekstra JB, DeVries JH.

J Diabetes Sci Technol. 2010 Jul 1;4(4):923-8.

19.

Artificial pancreas: fuzzy logic and control of glycemia.

Nimri R, Phillip M.

Curr Opin Endocrinol Diabetes Obes. 2014 Aug;21(4):251-6. doi: 10.1097/MED.0000000000000073. Review.

PMID:
24937038
20.

The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes.

O'Grady MJ, Retterath AJ, Keenan DB, Kurtz N, Cantwell M, Spital G, Kremliovsky MN, Roy A, Davis EA, Jones TW, Ly TT.

Diabetes Care. 2012 Nov;35(11):2182-7. doi: 10.2337/dc12-0761.

Items per page

Supplemental Content

Support Center